Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
Abstract This study was conducted to assess whether levetiracetam (LEV) affects the survival of patients with glioblastoma (GBM) treated with concurrent temozolomide (TMZ) chemotherapy. To this end, from 2004 to 2016, 322 patients with surgically resected and pathologically confirmed isocitrate dehy...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/c2151e0ede9f40f5bc078c0b974e815f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|